Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme

Angiotensin Receptor ◽

Heart Failure Patients ◽

Study Programme ◽

Treatment Data ◽

Worsening Renal Function and Outcome in Heart Failure Patients With Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2014.01.087 ◽

2014 ◽

Vol 64 (11) ◽

pp. 1106-1113 ◽

Cited By ~ 43

Author(s):

Kevin Damman ◽

Ana C. Perez ◽

Inder S. Anand ◽

Michel Komajda ◽

Robert S. McKelvie ◽

...

Keyword(s):

Heart Failure ◽

Renal Function ◽

Ejection Fraction ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Heart Failure Patients ◽

Worsening Renal Function ◽

Comparison of risk factors for acute worsening renal function in heart failure patients with and without preserved ejection fraction

European Journal of Internal Medicine ◽

10.1016/j.ejim.2015.08.003 ◽

2015 ◽

Vol 26 (8) ◽

pp. 599-602 ◽

Cited By ~ 3

Author(s):

Tamiharu Yamagishi ◽

Kenichi Matsushita ◽

Toshinori Minamishima ◽

Ayumi Goda ◽

Konomi Sakata ◽

...

Keyword(s):

Risk Factors ◽

Heart Failure ◽

Renal Function ◽

Ejection Fraction ◽

Heart Failure Patients ◽

250 The impact of an angiotensin converting enzyme inhibitor or an angiotensin receptor blocker on Doppler-echo diastolic and systolic parameters in heart failure with normal ejection fraction

European Journal of Echocardiography ◽

10.1016/s1525-2167(05)80103-9 ◽

2005 ◽

Vol 6 ◽

pp. S27-S27

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Angiotensin Converting Enzyme ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Normal Ejection Fraction ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

The Impact of Discontinuation of Sacubitril-Valsartan and Shifting to Angiotensin-Converting Enzyme inhibitor or Angiotensin Receptor Blocker in Patients with Heart Failure with Reduced Ejection Fraction

The Anatolian Journal of Cardiology ◽

10.14744/anatoljcardiol.2020.39267 ◽

2020 ◽

Author(s):

Osama A Amin

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Reduced Ejection Fraction ◽

Patients With Heart Failure ◽

Worsening renal function after diuresis among heart failure patients with preserved ejection fraction: a dilemma to heart failure management. Letter regarding the article ‘Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX‐AHF‐2 study’

European Journal of Heart Failure ◽

10.1002/ejhf.2050 ◽

2020 ◽

Author(s):

John L. Starwalt ◽

Amy F. Ho ◽

Hao Wang

Keyword(s):

Heart Failure ◽

Renal Function ◽

Ejection Fraction ◽

Left Ventricular ◽

Left Ventricular Ejection ◽

Heart Failure Management ◽

Ventricular Ejection Fraction ◽

Heart Failure Patients ◽

Worsening renal function after diuresis among heart failure patients with preserved ejection fraction: a dilemma to heart failure management: Reply

European Journal of Heart Failure ◽

10.1002/ejhf.2067 ◽

2020 ◽

Author(s):

Barry Greenberg ◽

Satit Janvanishstaporn ◽

Siting Feng

Keyword(s):

Heart Failure ◽

Renal Function ◽

Ejection Fraction ◽

Heart Failure Management ◽

Heart Failure Patients ◽

P6508Balance of risk and benefit of spironolactone according to renal function in heart failure patients with preserved ejection fraction

European Heart Journal ◽

10.1093/eurheartj/ehy566.p6508 ◽

2018 ◽

Vol 39 (suppl_1) ◽

Author(s):

I E Beldhuis ◽

P L Myhre ◽

B Claggett ◽

K Damman ◽

J C Fang ◽

...

Keyword(s):

Heart Failure ◽

Renal Function ◽

Ejection Fraction ◽

Heart Failure Patients ◽

Risk And Benefit

Prognostic Impact of Worsening Renal Function in Hospitalized Heart Failure Patients With Preserved Ejection Fraction: A Report From the JASPER Registry

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2019.04.009 ◽

2019 ◽

Vol 25 (8) ◽

pp. 631-642 ◽

Cited By ~ 3

Author(s):

Yu Sato ◽

Akiomi Yoshihisa ◽

Masayoshi Oikawa ◽

Toshiyuki Nagai ◽

Tsutomu Yoshikawa ◽

...

Keyword(s):

Heart Failure ◽

Renal Function ◽

Ejection Fraction ◽

Prognostic Impact ◽

Heart Failure Patients ◽

Renin–Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction

Circulation Heart Failure ◽

10.1161/circheartfailure.116.003588 ◽

2017 ◽

Vol 10 (2) ◽

Cited By ~ 32

Author(s):

Iris E. Beldhuis ◽

Koen W. Streng ◽

Jozine M. Ter Maaten ◽

Adriaan A. Voors ◽

Peter van der Meer ◽

...

Keyword(s):

Heart Failure ◽

Renal Function ◽

Ejection Fraction ◽

Renin Angiotensin System ◽

Angiotensin System ◽

Renin Angiotensin ◽

Heart Failure Patients ◽

The PARAGON Heart Failure trial – ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction

Blood Pressure ◽

10.1080/08037051.2019.1625523 ◽

2019 ◽

Vol 28 (4) ◽

pp. 215-216 ◽

Cited By ~ 2

Author(s):

Sverre E. Kjeldsen ◽

Krzysztof Narkiewicz ◽

Michel Burnier ◽

Suzanne Oparil

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Receptor Antagonist ◽

Angiotensin Receptor ◽

Angiotensin Receptor Antagonist ◽

Heart Failure Patients ◽

Heart Failure Trial ◽

Neprilysin Inhibitor